MicroRNA 339 down-regulates μ-opioid μeceptor at the post-transcriptional level in response to opioid treatment

FASEB Journal

Volumn 27, Issue 2, 2013, Pages 522-535

  Wu, Qifang ^a,b   Hwang, Cheol Kyu ^a   Zheng, Hui ^a,c   Wagley, Yadav ^a   Lin, Hong Yiou ^a   Kim, Do Kyung ^a,d   Law, Ping Yee ^a   Loh, Horace H ^a   Wei, Li Na ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b Center for Systems Biology   (United States)

^c GUANGZHOU INSTITUTES OF BIOMEDICINE AND HEALTH   (China)

^d Chosun University   (South Korea)

Author keywords

Fentanyl; Morphine; Promoter; UTR

Indexed keywords

FENTANYL; MICRORNA; MICRORNA 339 3P; MORPHINE; MU OPIATE RECEPTOR; NALOXONE; RNA; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ANIMAL CELL; ARTICLE; BINDING SITE; DOWN REGULATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; MICROARRAY ANALYSIS; MOUSE; NEGATIVE FEEDBACK; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION;

3' UNTRANSLATED REGIONS; ANALGESICS, OPIOID; ANIMALS; BASE SEQUENCE; CELL LINE; DOWN-REGULATION; FENTANYL; HEK293 CELLS; HIPPOCAMPUS; HUMANS; MICE; MICRORNAS; MORPHINE; NALOXONE; NARCOTIC ANTAGONISTS; PROMOTER REGIONS, GENETIC; RECEPTORS, OPIOID, MU; RNA PROCESSING, POST-TRANSCRIPTIONAL; RNA STABILITY; RNA, MESSENGER; UP-REGULATION;

EID: 84873468505     PISSN: None     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.12-213439     Document Type: Article

References (61)

1. Law, P. Y., Loh, H. H., and Wei, L. N. (2004) Insights into the receptor transcription and signaling: Implications in opioid tolerance and dependence. Neuropharmacology 47(Suppl. 1), 300-311
2. Binyaminy, B., Gafni, M., Shapira, M., and Sarne, Y. (2008) Agonist-specific down regulation of mu-opioid receptors: Different cellular pathways are activated by different opioid agonists. Life Sci. 82, 831-839
3. Kramer, H. K., and Simon, E. J. (1999) Role of protein kinase C (PKC) in agonist-induced mu-opioid receptor down-regulation: II. Activation and involvement of the alpha, epsilon, and zeta isoforms of PKC. J. Neurochem. 72, 594-604
4. Schmidt, H., Schulz, S., Klutzny, M., Koch, T., Handel, M., and Hollt, V. (2000) Involvement of mitogen-activated protein kinase in agonist-induced phosphorylation of the mu-opioid receptor in HEK 293 cells. J. Neurochem. 74, 414-422
5. Koch, T., Kroslak, T., Mayer, P., Raulf, E., and Hollt, V. (1997) Site mutation in the rat mu-opioid receptor demonstrates the involvement of calcium/calmodulin-dependent protein kinase II in agonist-mediated desensitization. J. Neurochem. 69, 1767-1770
6. Afify, E. A. (2002) Turnover of mu-opioid receptors in neuroblastoma cells. Brain Res. Mol. Brain Res. 106, 83-87
7. Wei, L. N., and Loh, H. H. (2011) Transcriptional and epigenetic regulation of opioid receptor genes: Present and future. Annu. Rev. Pharmacol. Toxicol. 51, 75-97
8. Kim, C. S., Hwang, C. K., Song, K. Y., Choi, H. S., Kim do, K., Law, P. Y., Wei, L. N., and Loh, H. H. (2008) Novel function of neuron-restrictive silencer factor (NRSF) for posttranscriptional regulation. Biochim. Biophys. Acta 1783, 1835-1846
9. Hwang, C. K., Kim, C. S., Kim do, K., Law, P. Y., Wei, L. N., and Loh, H. H. (2010) Up-regulation of the mu-opioid receptor gene is mediated through chromatin remodeling and transcriptional factors in differentiated neuronal cells. Mol. Pharmacol. 78, 58-68
10. Hwang, C. K., Song, K. Y., Kim, C. S., Choi, H. S., Guo, X. H., Law, P. Y., Wei, L. N., and Loh, H. H. (2009) Epigenetic programming of mu opioid receptor gene in mouse brain is regulated by MeCP2 and Brg1 chromatin remodeling factor. J. Cell. Mol. Med. 13, 3591-3615
11. Wu, Q., Law, P. Y., Wei, L. N., and Loh, H. H. (2008) Post-transcriptional regulation of mouse mu opioid receptor (MOR1) via its 3= untranslated region: A role for microRNA23b. FASEB J. 22, 4085-4095
12. Wu, Q., Zhang, L., Law, P. Y., Wei, L. N., and Loh, H. H. (2009) Long-term morphine treatment decreases the association of mu-opioid receptor (MOR1) mRNA with polysomes through miRNA23b. Mol. Pharmacol. 75, 744-750
13. He, Y., Yang, C., Kirkmire, C. M., and Wang, Z. J. (2010) Regulation of opioid tolerance by let-7 family microRNA targeting the mu opioid receptor. J. Neurosci. 30, 10251-10258
14. Mansour, A., Fox, C. A., Akil, H., and Watson, S. J. (1995) Opioid-receptor mRNA expression in the rat CNS: Anatomical and functional implications. Trends Neurosci. 18, 22-29
15. Brodsky, M., Elliott, K., Hynansky, A., Jenab, S., and Inturrisi, C. E. (1995) Quantitation of mu-opioid receptor (MOR-1) mRNA in selected regions of the rat CNS. Neuroreport 6, 725-729
16. Unterwald, E. M., Rubenfeld, J. M., Imai, Y., Wang, J. B., Uhl, G. R., and Kreek, M. J. (1995) Chronic opioid antagonist administration upregulates mu opioid receptor binding without altering mu opioid receptor mRNA levels. Brain Res. Mol. Brain Res. 33, 351-355
17. Pan, Y. X., Xu, J., Mahurter, L., Bolan, E., Xu, M., and Pasternak, G. W. (2001) Generation of the mu opioid receptor (MOR-1) protein by three new splice variants of the Oprm gene. Proc. Natl. Acad. Sci. U. S. A. 98, 14084-14089
18. Van Rooij, E. (2011) The art of microRNA research. Circ. Res. 108, 219-234
19. Denli, A. M., Tops, B. B., Plasterk, R. H., Ketting, R. F., and Hannon, G. J. (2004) Processing of primary microRNAs by the microprocessor complex. Nature 432, 231-235
20. Gregory, R. I., Yan, K. P., Amuthan, G., Chendrimada, T., Doratotaj, B., Cooch, N., and Shiekhattar, R. (2004) The microprocessor complex mediates the genesis of microRNAs. Nature 432, 235-240
21. Lee, Y., Ahn, C., Han, J., Choi, H., Kim, J., Yim, J., Lee, J., Provost, P., Radmark, O., Kim, S., and Kim, V. N. (2003) The nuclear RNase III Drosha initiates microRNA processing. Nature 425, 415-419
22. Yi, R., Qin, Y., Macara, I. G., and Cullen, B. R. (2003) Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs. Genes Dev. 17, 3011-3016
23. Chendrimada, T. P., Gregory, R. I., Kumaraswamy, E., Norman, J., Cooch, N., Nishikura, K., and Shiekhattar, R. (2005) TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing. Nature 436, 740-744
24. Zheng, H., Zeng, Y., Zhang, X., Chu, J., Loh, H. H., and Law, P. Y. (2010) mu-Opioid receptor agonists differentially regulate the expression of miR-190 and NeuroD. Mol. Pharmacol. 77, 102-109
25. Chakrabarti, S., Law, P. Y., and Loh, H. H. (1995) Neuroblastoma Neuro2A cells stably expressing a cloned mu-opioid receptor: A specific cellular model to study acute and chronic effects of morphine. Brain Res. Mol. Brain Res. 30, 269-278
26. Hwang, C. K., Kim, C. S., Choi, H. S., McKercher, S. R., and Loh, H. H. (2004) Transcriptional regulation of mouse mu opioid receptor gene by PU. 1. J. Biol. Chem. 279, 19764-19774
27. Hwang, C. K., Law, P. Y., Wei, L. N., and Loh, H. H. (2011) Regulation of the transcription of G protein-coupled receptor genes. In: Methods for the Discovery and Characterization of G Protein-Coupled Receptors (Stevens, C. W., ed) Vol. 60, Humana Press, Clifton, NJ, USA
28. McBurney, M. W., Reuhl, K. R., Ally, A. I., Nasipuri, S., Bell, J. C., and Craig, J. (1988) Differentiation and maturation of embryonal carcinoma-derived neurons in cell culture. J. Neurosci. 8, 1063-1073
29. Hwang, C. K., Song, K. Y., Kim, C. S., Choi, H. S., Guo, X. H., Law, P. Y., Wei, L. N., and Loh, H. H. (2007) Evidence of endogenous mu opioid receptor regulation by epigenetic control of the promoters. Mol. Cell. Biol. 27, 4720-4736
30. Jalali, A., Bassuk, A. G., Kan, L., Israsena, N., Mukhopadhyay, A., McGuire, T., and Kessler, J. A. (2011) HeyL promotes neuronal differentiation of neural progenitor cells. J. Neurosci. Res. 89, 299-309
31. Wang, Y., Liu, C. L., Storey, J. D., Tibshirani, R. J., Herschlag, D., and Brown, P. O. (2002) Precision and functional specificity in mRNA decay. Proc. Natl. Acad. Sci. U. S. A. 99, 5860-5865
32. Ross, J. (1995) mRNA stability in mammalian cells. Microbiol. Rev. 59, 423-450
33. Wagley, Y., Yoo, Y. C., Seo, H. G., Rhee, M. H., Kim, T. H., Kang, K. W., Nah, S. Y., and Oh, J. W. (2007) The IL-6/sIL-6R treatment of a malignant melanoma cell line enhances susceptibility to TNF-induced apoptosis. Biochem. Biophys. Res. Commun. 354, 985-991
34. Karaji, A. G., Khansari, N., Ansary, B., and Dehpour, A. (2005) Detection of opioid receptors on murine lymphocytes by indirect immunofluorescence: Mature normal and tumor bearing mice lymphocytes. Int. Immunopharmacol. 5, 1019-1027
35. Huang, H. Y., Chien, C. H., Jen, K. H., and Huang, H. D. (2006) RegRNA: An integrated web server for identifying regulatory RNA motifs and elements. Nucleic Acids Res. 34, W429-W434
36. Lewis, B. P., Burge, C. B., and Bartel, D. P. (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120, 15-20
37. Chen, H. C., Wei, L. N., and Loh, H. H. (1999) Expression of mu-, kappa-and delta-opioid receptors in P19 mouse embryonal carcinoma cells. Neuroscience 92, 1143-1155
38. Law, P.-Y. (2011) Opioid receptor signal transduction mechanisms. In: The Opiate Receptors (Pasternak, G. W., ed) Vol. 23, pp. 195238, Springer Science-Business Media, New York
39. Im, H. J., Smirnov, D., Yuhi, T., Raghavan, S., Olsson, J. E., Muscat, G. E., Koopman, P., and Loh, H. H. (2001) Transcriptional modulation of mouse mu-opioid receptor distal promoter activity by Sox 18. Mol. Pharmacol. 59, 1486-1496
40. Cai, X., Hagedorn, C. H., and Cullen, B. R. (2004) Human microRNAs are processed from capped, polyadenylated transcripts that can also function as mRNAs. RNA 10, 1957-1966
41. Lee, Y., Kim, M., Han, J., Yeom, K. H., Lee, S., Baek, S. H., and Kim, V. N. (2004) MicroRNA genes are transcribed by RNA polymerase II. EMBO J. 23, 4051-4060
42. Monteys, A. M., Spengler, R. M., Wan, J., Tecedor, L., Lennox, K. A., Xing, Y., and Davidson, B. L. (2010) Structure and activity of putative intronic miRNA promoters. RNA 16, 495-505
43. Reese, M. G. (2001) Application of a time-delay neural network to promoter annotation in the Drosophila melanogaster genome. Comput. Chem. 26, 51-56
44. Messeguer, X., Escudero, R., Farre, D., Nunez, O., Martinez, J., and Alba, M. M. (2002) PROMO: Detection of known transcription regulatory elements using species-tailored searches. Bioinformatics 18, 333-334
45. Solovyev, V. V., Shahmuradov, I. A., and Salamov, A. A. (2010) Identification of promoter regions and regulatory sites. Methods Mol. Biol. 674, 57-83
46. Wu, Q., Hwang, C. K., Yao, S., Law, P. Y., Loh, H. H., and Wei, L. N. (2005) A major species of mouse mu-opioid receptor mRNA and its promoter-dependent functional polyadenylation signal. Mol. Pharmacol. 68, 279-285
47. Taganov, K. D., Boldin, M. P., Chang, K. J., and Baltimore, D. (2006) NF-?B-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc. Natl. Acad. Sci. U. S. A. 103, 12481-12486
48. Xiong, H., Qian, J., He, T., and Li, F. (2009) Independent transcription of miR-281 in the intron of ODA in Drosophila melanogaster. Biochem. Biophys. Res. Commun. 378, 883-889
49. Lau, N. C., Lim, L. P., Weinstein, E. G., and Bartel, D. P. (2001) An abundant class of tiny RNAs with probable regulatory roles in Caenorhabditis elegans. Science 294, 858-862
50. Lagos-Quintana, M., Rauhut, R., Lendeckel, W., and Tuschl, T. (2001) Identification of novel genes coding for small expressed RNAs. Science 294, 853-858
51. Lee, R. C., and Ambros, V. (2001) An extensive class of small RNAs in Caenorhabditis elegans. Science 294, 862-864
52. Jeal, W., and Benfield, P. (1997) Transdermal fentanyl. A review of its pharmacological properties and therapeutic efficacy in pain control. Drugs 53, 109-138
53. Pergolizzi, J., Boger, R. H., Budd, K., Dahan, A., Erdine, S., Hans, G., Kress, H. G., Langford, R., Likar, R., Raffa, R. B., and Sacerdote, P. (2008) Opioids and the management of chronic severe pain in the elderly: Consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone). Pain Pract. 8, 287-313
54. Duttaroy, A., and Yoburn, B. C. (1995) The effect of intrinsic efficacy on opioid tolerance. Anesthesiology 82, 1226-1236
55. Mayes, S., and Ferrone, M. (2006) Fentanyl HCl patient-controlled iontophoretic transdermal system for the management of acute postoperative pain. Ann. Pharmacother. 40, 2178-2186
56. Zheng, H., Zeng, Y., Chu, J., Kam, A. Y., Loh, H. H., and Law, P. Y. (2010) Modulations of NeuroD activity contribute to the differential effects of morphine and fentanyl on dendritic spine stability. J. Neurosci. 30, 8102-8110
57. Kelkar, Y. D., Strubczewski, N., Hile, S. E., Chiaromonte, F., Eckert, K. A., and Makova, K. D. (2010) What is a microsatellite: A computational and experimental definition based upon repeat mutational behavior at A/T and GT/AC repeats. Genome Biol. Evol. 2, 620-635
58. Wu, H., Caffo, B., Jaffee, H. A., Irizarry, R. A., and Feinberg, A. P. (2010) Redefining CpG islands using hidden Markov models. Biostatistics 11, 499-514
59. Akan, P., and Deloukas, P. (2008) DNA sequence and structural properties as predictors of human and mouse promoters. Gene 410, 165-176
60. Kim, D. K., Hwang, C. K., Wagley, Y., Law, P. Y., Wei, L. N., and Loh, H. H. (2011) p38 mitogen-activated protein kinase and PI3-kinase are involved in up-regulation of mu opioid receptor transcription induced by cycloheximide. J. Neurochem. 116, 1077-1087
61. Pan, Y. X. (2002) Identification and characterization of a novel promoter of the mouse mu opioid receptor gene (Oprm) that generates eight splice variants. Gene 295, 97-108